Glo-Med Networks, Inc.

A company that delivers unique healthcare solutions and collaborates with top medical device and biomedical companies worldwide.

CCI Score

28.16

-0.01% April 18

Latest Event

Glo-Med Networks Leads Deployment of INSPIRA ART100 at Westchester Medical Center

Glo-Med Networks, Inc. led the installation, training, and professional services for the clinical implementation of the FDA-cleared INSPIRA ART100 system during a critical life-support procedure at Westchester Medical Center on April 07, 2025. This action facilitated a significant advancement in patient care and the adoption of innovative healthcare technology.

Take Action

So what can you do? Support by shopping, spreading the word, or offering your support.

Shop Alternatives SEE ALL: Datavant

Mphasis

Abridge
Use Your Voice OTHER TOOLS
Investigate
Share the Score SUPPORT CCI

DISSENTER

Glo-Med Networks, Inc. is currently rated as a Dissenter.

+25 to +44 CCI Score

These companies are vocal in their opposition to authoritarian regimes. They publicly criticize oppressive policies and engage in advocacy efforts to promote accountability and transparency, even if their actions aren’t as extensive as those of Moral Leaders.

Latest Events

APR

07

2025

Glo-Med Networks Leads Deployment of INSPIRA ART100 at Westchester Medical Center
40.00

Glo-Med Networks, Inc. led the installation, training, and professional services for the clinical implementation of the FDA-cleared INSPIRA ART100 system during a critical life-support procedure at Westchester Medical Center on April 07, 2025. This action facilitated a significant advancement in patient care and the adoption of innovative healthcare technology.
JAN

31

2022

Glo-Med Networks Signs Strategic Distribution Agreement
16.31

Glo-Med Networks entered an exclusive, 7‐year distribution agreement with Inspira Technologies to distribute its innovative ART respiratory support system across six U.S. states. The deal, pending regulatory approvals, is expected to expand access to cutting‑edge healthcare technology and improve patient outcomes.
+25

Business Practices and Ethical Responsibility

April 7

The agreement demonstrates ethical business practices by fostering long-term global partnerships and ensuring access to innovative medical devices that can improve patient care. This not only enhances Glo-Med’s role in the healthcare supply chain but also supports community well-being.

Inspira Technologies Signs a Strategic Agreement in the U.S. to Target $212 Million for Inspira Over a 7-Year Period, Subject to Regulatory Approvals
+20

Technology and Services Impact

April 7

By facilitating the distribution of the ART respiratory support system, the agreement advances technological innovation in healthcare. The ART system’s potential to reduce reliance on invasive treatments further supports improved health outcomes for vulnerable populations.

Inspira Technologies Signs a Strategic Agreement in the U.S. to Target $212 Million for Inspira Over a 7-Year Period, Subject to Regulatory Approvals